India, Africa Union Postpone New Delhi Summit Amid Ebola Outbreak
India and the African Union said new dates will be set later as WHO warned the outbreak is a public health emergency of international concern.
- On Thursday, India and the African Union postponed the Fourth India-Africa Forum Summit scheduled for May 28-31 in New Delhi, citing the evolving health situation in parts of Africa following consultations between both sides.
- The World Health Organization declared the 17th Ebola outbreak in the DRC a public health emergency Friday, reporting 600 suspected cases and 139 suspected deaths from a rare Bundibugyo strain circulating undetected for about two months.
- Over 920,000 internally displaced people in Ituri face immense pressure from conflict and a collapsing health system, said Dr. Lievin Bangali, Senior Health Coordinator for the International Rescue Committee in DRC.
- India pledged solidarity with African governments and committed to supporting Africa CDC-led efforts to strengthen public health preparedness across the continent, reaffirming cooperation despite the summit postponement.
- British scientists at Oxford are fast-tracking a vaccine for trials within months, though independent analysts estimate actual cases could exceed 1,000—far higher than official figures—suggesting the outbreak's true scale remains uncertain.
91 Articles
91 Articles
Suspension of India-Africa Forum Summit 2026
The 4th India-Africa Forum Summit (IAFS-IV), originally scheduled for May 28 to May 31, 2026, in New Delhi, has been deferred to a later date due to the high risks of the Ebola virus, which is emerging and rapidly spreading from the Democratic Republic of Congo (DRC) in the central African region. The African Union […] The post Suspension of India-Africa Forum Summit 2026 appeared first on Modern Diplomacy.
NEWS HEADLINES: UK Researchers “Urgently” Developing Ebola Vaccine Based On Platform Used For Oxford/AstraZeneca COVID-19 Jab * 100PercentFedUp.com * by Danielle
Researchers at the Oxford Vaccine Group (OVG) are working “urgently” to development a vaccine for “Bundibugyo Ebolavirus” amid an outbreak in Africa. “In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford’s own Clinical BioManufacturing Facility and the Serum Institute of India Pvt. Ltd. (SIIPL), to rapidly produce and scale doses of our C…
BREAKING: UK Researchers Fast-Track Ebola Vaccine Following Outbreak In Congo
UK researchers are mobilizing quickly to develop a new Ebola vaccine, drawing on the same technology behind the Oxford/AstraZeneca COVID-19 vaccine. This urgent action corresponds with the emergence of the Bundibugyo strain of Ebola in the Democratic Republic of Congo, where authorities are already labeling the outbreak as “spreading rapidly.” The Oxford Vaccine Group (OVG) has announced plans for its candidate vaccine, ChAdOx1 BDBV. If animal t…
Coverage Details
Bias Distribution
- 36% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
